Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jose Ramon Azanza"'
Autor:
Belen Sadaba, Anabel del Barrio, Miguel Angel Campanero, Jose Ramon Azanza, Almudena Gomez-Guiu, Jose Maria Lopez-Picazo, Salvador Martin Algarra, Francisco Guillén Grimá, Maria Blanco Prieto, Jose Luis Perez-Gracia, Alfonso Gurpide
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e89747 (2014)
Palonosetron is a potent second generation 5- hydroxytryptamine-3 selective antagonist which can be administered by either intravenous (IV) or oral routes, but subcutaneous (SC) administration of palonosetron has never been studied, even though it co
Externí odkaz:
https://doaj.org/article/732bd83ce7fe475ebabe0fd50f2fd1e3
Autor:
Carlos Chaccour, Paula Ruiz-Castillo, Mary-Ann Richardson, Gemma Moncunill, Aina Casellas, Francisco Carmona-Torre, Miriam Giráldez, Juana Schwartz Mota, José Ramón Yuste, José Ramón Azanza, Miriam Fernández, Gabriel Reina, Carlota Dobaño, Joe Brew, Belen Sadaba, Felix Hammann, Regina Rabinovich
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-4 (2020)
Abstract Objectives The primary objective is to determine the efficacy of a single dose of ivermectin, administered to low risk, non-severe COVID-19 patients in the first 48 hours after symptom onset to reduce the proportion of patients with detectab
Externí odkaz:
https://doaj.org/article/d7c0183d2e3843dbb71c302b19ff9439
Autor:
Paula Rodriguez-Otero, Joana Reis, Ana Alfonso-Pierola, Diego Salas-Benito, Miriam Giraldez, Jose Ramón Azanza, Mariano Ponz-Sarvise
Publikováno v:
JCO Global Oncology, Vol , Iss 6, Pp 904-905 (2020)
Externí odkaz:
https://doaj.org/article/0e1d28ba105a4421ba185be8e103022a